• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Home oxygen therapy for bronchiolitis feasible, cost-effective, and favorable to caregivers

byMatthew Dawson, MDandAlex Gipsman, MD
September 12, 2022
in Infectious Disease, Pediatrics, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A systematic review of international literature suggests that home oxygen therapy for bronchiolitis is well-received by parents and caregivers and can reduce hospital costs.

2. Available evidence, though limited, demonstrates low readmission rates and minimal use of intensive care among infants with bronchiolitis treated with home oxygen.

Evidence Rating Level: 2 (Good)

Study Rundown: COVID waves coinciding with seasonal bronchiolitis spikes have demonstrated the demand that respiratory illnesses can place on pediatric hospital systems. Home care models for bronchiolitis could alleviate the hospital burden of this illness. A systematic review of studies published in the last twenty years identified ten which examine the use of home oxygen therapy in the treatment of bronchiolitis. Twenty-five to fifty percent of patients diagnosed with bronchiolitis met the studies’ variable criteria for home oxygen treatment, with 70-82% of those patients successfully discharged to receive care at home.  Safety and patient outcomes were favorable, with a readmission rate of approximately 6% of those patients treated with home oxygen. Two studies assessed caregiver reception of treatment, with a plurality of parent/guardians preferring home treatment to hospitalization. Savings to the health care system were estimated to be approximately $1500-$4000 per patient encounter, with wide variability based on the studied health care system. However, significant study limitations prevent generalizability. No RCTs included in the review were adequately powered, and the highest quality studies all occurred in hospital systems at altitude, making extrapolation to sea-level challenging. Multiple studies included patients aged > 1 year, risking capture of other respiratory conditions besides bronchiolitis in their study population. Despite these limitations, the available body of evidence encourages continued exploration of the home care model for bronchiolitis. Remote monitoring / telemedicine models and at-home nasogastric feeding and rehydration, though understudied, may provide additional avenues of research in the ongoing effort to reduce the burden of bronchiolitis on the pediatric healthcare system.

Click to read the study in PEDIATRICS

Click to read an accompanying editorial in PEDIATRICS

RELATED REPORTS

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis

Relevant Reading: Emergency Department–initiated Home Oxygen for Bronchiolitis: A Prospective Study of Community Follow-up, Caregiver Satisfaction, and Outcomes

In-Depth [systematic review]: This systematic review searched across five medical literature databases and screened >1300 studies, identifying 10 that examined infants with bronchiolitis managed with at-home oxygen therapy. The studies included randomized control trials, prospective cohort studies and retrospective chart reviews across the United States, Australia, and Canada. Despite including search terms for at-home nasogastric tube hydration and remote monitoring, no literature examining these interventions were identified that met inclusion criteria. Across all studies, 25-50% of infants with bronchiolitis were eligible for at-home treatment with 70-82% discharged with home oxygen therapy. One study noted a 68% success rate with at-home treatment. Readmission rates ranged from 2.4% to 9.4% (n=79 of 1257 in the pooled population across five studies), with no significant difference in populations at higher altitudes when compared to those at sea level. Only three patients in this cohort required escalation to intensive care, with one requiring intubation. Two studies assessed caregiver satisfaction, with preference for home oxygen therapy over hospitalization ranging from 79-88% across studies. Cost analysis varied widely by system, but savings estimates per encounter ranged from $1200-$4100 across studies, with no studies commenting on familial or societal savings. Study bias was assessed using the Quality Assessment with Diverse Studies guidelines. Both RCTs were noted to be underpowered; two large population studies were confounded with the simultaneous use of an observational unit and home oxygen therapy model. Several studies were noted to have variation in the ages and characteristics of their populations.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.  

Tags: bronchiolitiscost savingshome oxygen therapy
Previous Post

Routine dexamethasone is not effective compared to placebo to treat dyspnea in patients with advanced cancer

Next Post

Open-source automated insulin delivery is effective in management of type 1 diabetes

RelatedReports

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Pharma

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

February 24, 2025
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
StudyGraphics

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

October 7, 2024
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
StudyGraphics

#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis

July 22, 2024
High error rate among parents measuring liquid medications
Infectious Disease

Respiratory syncytial virus disproportionately affects pre-term infants over term infants

April 25, 2024
Next Post
Pediatric DKA associated with recent acute care visits

Open-source automated insulin delivery is effective in management of type 1 diabetes

Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren

Repeated low-level red light therapy significantly slows progression of myopia in children

Pediatric renal and thyroid cancer rates increase

Telaglenastat addition to cabozantinib did not demonstrate benefit in pre-treated advanced renal cell carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin D Levels During Pregnancy and Dental Caries in Offspring
  • Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome: 10 year follow-up of the FIMPACT randomised, placebo surgery controlled trial 
  • Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.